Paraganglioma: Clinical Trials

3 trials for Paraganglioma, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

2 recruiting, 1 active not recruiting. 3 Early Phase 1.

By phase and status

PhaseTrialsStatus
Early Phase 13Recruiting 2, Active not recruiting 1

Follow Paraganglioma: new trials by email Literature Review of Paraganglioma trials Research Report on Paraganglioma

Trials (filtered) newest first · largest first

All 3 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
In Vivo PARP-1 Expression With 18F-FluorThanatrace PET/CT in Patients With Pheochromocytoma and Paraganglioma
[18F]FluorThanatrace ([18F]FTT) - Pheochromocytoma, Paraganglioma
Early Phase 1RecruitingHeather Wachtel302023-07-012026-02-27
18F-MFBG PET/CT in the Evaluation of Neural Crest Tumor
18F-MFBG, 68Ga-Dotatate - Neuroendocrine Tumor, Neuroblastoma
Early Phase 1RecruitingPeking Union Medical College Hospital1502021-09-012024-03-01
18F-Fluorodopamine PET Studies of Neuroblastoma and Pheochromocytoma
18F-DA - Neuroblastoma, Pheochromocytoma
Early Phase 1Active not recruitingSt. Jude Children's Research Hospital132019-04-302026-06-17

Narrower conditions

Pheochromocytoma (3)  ·  Neuroblastoma (2)  ·  Neuroendocrine Tumors (1)

Broader conditions

Neoplasms (3)  ·  Neoplasms by Histologic Type (3)  ·  Neoplasms, Germ Cell and Embryonal (3)  ·  Neoplasms, Nerve Tissue (3)  ·  Neuroectodermal Tumors (3)  ·  Neoplasms, Glandular and Epithelial (2)  ·  Neoplasms, Neuroepithelial (2)  ·  Neuroectodermal Tumors, Primitive (2)  ·  Neuroectodermal Tumors, Primitive, Peripheral (2)  ·  Neuroendocrine Tumors (2)

Interventions

3-fluorobenzylguanidine (1)  ·  6-fluorodopamine (1)  ·  gallium Ga 68 dotatate (1)

Sponsors

Heather Wachtel (1)  ·  Peking Union Medical College Hospital (1)  ·  St. Jude Children's Research Hospital (1)

Countries

United States (2)  ·  China (1)

Top investigators

Barry Shulkin, MD (1)  ·  Fang Li (1)  ·  Heather Wachtel, MD (1)

Results publications

PMID 37160439, PMID 40717185